Press "Enter" to skip to content

U.S. FDA grants emergency use authorization to Regeneron Covid-19 antibody given to Trump

Highlights

The U.S. Food and Drug Administration on Saturday issued emergency use authorization for Regeneron Pharmaceuticals Inc’s Covid-19 antibody therapy, an experimental treatment given to U.S. President Donald Trump that he said helped cure him of the disease.

The FDA said the monoclonal antibodies, casirivimab and imdevimab, should be administered together for the treatment of mild to moderate Covid-19 in adults and pediatric patients with positive results of direct SARS-CoV-2 viral testing and who are at high risk for progressing to severe Covid-19.

This includes those who are 65 years of age or older or who have certain chronic medical conditions.

Amnon Free Press:  “SNL” Features Jim Carrey’s Biden Reading Scary Story, Makes Fun Of Nate Silver Election Predictions

The treatment is part of a class of drugs known as monoclonal antibodies, which are manufactured copies of antibodies created by the human body to fight infections.

Regeneron’s REGEN-COV2 “antibody cocktail” – containing an antibody made by the company and a second isolated from humans who recovered from Covid-19 – is designed so that the two antibodies seek out and bind to the coronavirus’ spike protein to prevent it from entering healthy human cells.

Regeneron said on Saturday the clinical evidence from outpatient trial suggests that monoclonal antibodies such as REGEN-COV2 have the greatest benefit when given early after diagnosis and in patients who have not yet mounted their own immune response or who have high viral load.

Amnon Free Press:  Warnock in 2009: ‘Sick and Tired’ of Attacks on Socialism

The company said it expects to have does of REGEN-COV2 treatment ready for about 80,000 patients by the end of this month, about 200,000 patients by the first week of January and approximately 300,000 patients in total by the end of January.

The FDA said the antibodies are not authorized for patients who are hospitalized due to Covid-19 or require oxygen therapy due to Covid-19. — Reuters

As reported by Highlights. Continue reading this article at Highlights

Amnon Free Press:  Meet the new Miss USA: Asya Branch, 22, is a gun-loving Trump fan from Mississippi who has met the President at the White House and believes the country has 'lost trust' in the media

All news text, graphics, videos and multimedia content remain the copyrights of the credited original article publisher, in this case - Highlights

Amnon Free Press is an American conservative news aggregator and publisher with a mission to publish the right news for the right American.

Contact Information: admin (at) amnonfreepress dot com